ENTA — Enanta Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $339.02m
- $275.90m
- $65.32m
Enanta Pharmaceuticals Q3 revenue misses estimates, hurt by lower royalties
Enanta Pharmaceuticals Inc expected to post a loss of 51 cents a share - Earnings Preview
Enanta Pharma Q2 loss narrows on higher AbbVie royalties, lower costs
Enanta Pharmaceuticals Q1 revenue beats estimates
Enanta Pharmaceuticals Q4 revenue rises, helped by higher sales of AbbVie's MAVYRET/MAVIRET
Brief: Enanta Pharmaceuticals Q4 Revenue USD 15.125 Million
U.S. RESEARCH ROUNDUP-Disney, Enanta Pharmaceuticals, Phillips 66
Brief: Enanta Pharmaceuticals Announces Closing Of Upsized Public Offering Of Common Stock
Enanta Pharma slides on upsized $65 mln stock offering
Brief: Enanta Pharmaceuticals Prices Upsized Offering Of 6,500,000 Shares At $10 Each
Brief: Enanta Pharmaceuticals Announces $50 Million Public Offering Of Common Stock
Enanta Pharma slides after $50 mln stock offering unveiled
U.S. STOCKS ON THE MOVE-Electronic Arts, Copper miners, Occidental Petroleum
U.S. STOCKS ON THE MOVE-Rare Earth, Copper miners, Gold miners
Enanta falls after co's RSV treatment fails main goal in mid-stage study
Enanta's RSV treatment misses main goal in mid-stage study (updated)
Enanta's RSV treatment misses main goal in mid-stage study
Brief: Enanta Pharmaceuticals Reports Positive Phase 2b Results for RSV Drug Zelicapavir
Brief: Enanta Pharmaceuticals Appoints Harry R. Trout As Interim Principal Financial Officer